hg_162715.1

Basic information about the TSS

---

TSS ID: hg_162715.1 Species: human Chr: chr17		Start: 75261864 End: 75261904 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000245539.11 NM_015971 AK313854 JF432776 KJ898818 Distance: 0 GeneID: 51081 HGNC/MGI_ID: HGNC:14499 UniProt_ID: A0A024R8L0 Q9Y2R9

Gene_name: mitochondrial ribosomal protein S7 Gene_symbol: MRPS7 Gene_synonyms: MRP-S RP-S7 RPMS7 Gene_source: HGNC:14499

TATA-Box annotation

---

Distance to TSS:	5
Nearest PromoterID:	NM_015971
Entrez ID:	51081
Nearest Unigene:	Hs.71787
Nearest Refseq:	NM_015971
Nearest Ensembl:	ENSG00000125445
Gene Name:	mitochondrial ribosomal protein S7
Gene Alias:	COXPD34|MRP-S|MRP-S7|RP-S7|RPMS7|S7mt|bMRP27a
Gene Description:	mitochondrial ribosomal protein S7
Gene Type:	protein-coding
CpG%:	0.075
GC%:	0.641791
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MRPS7 p2@MRPS7 p3@MRPS7
Sample		p1@MRPS7	p2@MRPS7	p3@MRPS7
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	36.62	55.32	1.75
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.99	51.59	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	36.07	56.14	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	27.65	43.66	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	35.32	52.64	2.47
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.14	54.85	1.74
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	57.96	62.10	2.40
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	45.30	56.68	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	41.46	50.65	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	25.50	62.02	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	28.30	62.25	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	31.71	51.63	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	47.23	3.22	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	40.90	2.26	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	45.23	3.07	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	41.75	1.51	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	37.13	3.71	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	43.87	2.95	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	30.92	4.27	3.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	49.95	3.16	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	45.31	4.95	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	44.71	5.70	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	44.98	3.49	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	48.05	1.70	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	44.89	3.61	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	46.53	4.11	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	45.06	2.20	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	57.29	5.89	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	47.65	4.20	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	53.20	5.43	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	54.85	5.44	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	52.56	4.49	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.99	7.81	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	62.18	5.77	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	56.10	5.61	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.86	4.60	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	62.95	5.72	2.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	54.20	4.84	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	64.01	7.56	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	61.22	5.52	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	52.93	7.53	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	59.00	6.44	2.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	54.83	3.59	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	48.43	5.07	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	63.64	6.63	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	53.28	5.82	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	52.30	5.04	1.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	56.63	5.07	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	51.23	5.74	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	54.59	4.85	3.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	50.21	4.51	2.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	49.14	4.45	2.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.78	4.61	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	47.39	3.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	38.59	13.42	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	49.14	8.27	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.89	3.24	2.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	42.07	4.82	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	65.07	5.66	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	23.27	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	29.72	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	58.12	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	46.55	3.06	4.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	28.27	2.92	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	45.44	4.26	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	28.76	3.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	37.69	0.99	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	33.78	2.35	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	48.35	6.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	37.74	3.40	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	31.49	2.45	0.92
Adipocyte - breast, donor1	11376-118A8	28.98	3.48	0.16
Adipocyte - breast, donor2	11327-117E4	30.16	3.53	0.00
Adipocyte - omental, donor1	11473-119C6	30.79	4.33	0.13
Adipocyte - omental, donor2	11474-119C7	39.62	3.74	0.00
Adipocyte - omental, donor3	11475-119C8	36.84	4.69	0.00
Adipocyte - perirenal, donor1	11476-119C9	37.64	1.28	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	25.29	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	18.52	3.16	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	26.59	2.61	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	35.40	2.54	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	18.79	3.09	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	34.57	3.35	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	31.15	3.53	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	58.64	10.54	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	31.31	4.20	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	28.79	5.33	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	36.72	8.90	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	69.87	15.39	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	38.43	6.03	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	36.65	4.58	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	42.32	10.35	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	48.40	10.61	4.42
Alveolar Epithelial Cells, donor2	11590-120G6	43.03	5.02	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	37.96	8.28	5.40
Amniotic Epithelial Cells, donor2	11613-122A2	40.16	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	43.55	3.90	0.41
Anulus Pulposus Cell, donor1	11248-116E6	27.46	1.95	5.84
Anulus Pulposus Cell, donor2	11463-119B5	24.98	2.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	25.61	3.15	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	29.09	3.47	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.53	3.89	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	28.38	1.98	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	23.07	3.25	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	19.42	5.34	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.76	3.56	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	29.75	4.52	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	28.30	5.08	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	18.81	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.01	4.28	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	27.29	3.32	0.90
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	24.65	4.29	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.15	3.78	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.19	3.21	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	4.88	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.05	1.99	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	19.90	2.92	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	25.73	3.40	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	28.08	4.93	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	6.06	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	25.08	2.85	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.52	0.86	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.26	0.77	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	22.99	4.69	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	24.44	2.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	26.40	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	18.72	2.92	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	22.28	3.01	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	33.26	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	25.94	3.05	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	24.45	2.80	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	27.96	3.18	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	23.30	6.04	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	27.31	1.91	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	27.26	2.32	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	25.51	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.34	2.20	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	23.37	2.79	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	20.46	4.21	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	26.24	4.37	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.68	2.76	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	22.95	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.19	3.81	1.78
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.53	1.03	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	22.03	3.37	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.25	3.35	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	24.17	3.77	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	25.48	2.22	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	24.89	1.32	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.62	1.45	0.36
Astrocyte - cerebellum, donor1	11500-119F6	51.34	6.39	14.74
Astrocyte - cerebellum, donor2	11580-120F5	48.27	3.42	1.54
Astrocyte - cerebellum, donor3	11661-122F5	25.59	3.99	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	43.22	4.88	10.46
Astrocyte - cerebral cortex, donor2	11316-117D2	52.41	9.06	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	48.33	7.01	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	43.24	9.29	2.64
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.86	12.90	2.76
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	46.54	10.70	3.07
Basophils, donor1	12241-129G9	15.95	6.02	1.57
Basophils, donor2	12242-129H1	21.65	6.86	2.53
Basophils, donor3	12243-129H2	13.08	2.65	3.97
Bronchial Epithelial Cell, donor1	11511-119G8	23.29	5.61	4.53
Bronchial Epithelial Cell, donor2	11591-120G7	26.06	1.37	2.29
Bronchial Epithelial Cell, donor3	11672-122G7	57.39	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	69.04	7.53	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	60.72	7.07	1.25
Bronchial Epithelial Cell, donor6	11461-119B3	37.31	5.53	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	32.57	2.70	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	42.25	9.58	22.36
Burkitt's lymphoma cell line:RAJI	10476-106I8	61.72	16.30	15.84
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	47.65	12.15	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	10.14	3.38	1.13
CD14+ Monocytes, donor2	11305-117B9	8.54	1.30	0.37
CD14+ Monocytes, donor3	11381-118B4	13.61	3.51	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.25	5.66	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	45.11	6.07	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	46.02	8.55	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	11.27	3.47	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	11.16	1.21	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	13.03	5.21	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.03	2.34	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	6.07	4.97	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.96	6.20	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.09	3.52	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.48	2.67	1.25
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.92	6.96	4.13
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.21	3.51	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	5.81	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	13.31	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.69	4.02	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	7.98	2.39	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.58	3.96	3.75
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.72	2.52	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	6.11	4.07	3.39
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	2.62	5.67	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	9.95	1.88	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	11.17	4.19	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	15.15	2.95	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.39	2.02	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	2.82	3.17	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	3.07	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.71	2.79	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.20	3.35	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	12.50	7.11	5.60
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	8.19	2.05	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.25	2.55	4.87
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	5.34	5.34	4.18
CD14+CD16+ Monocytes, donor1	11789-124B7	35.53	4.14	3.92
CD14+CD16+ Monocytes, donor2	11801-124D1	32.57	2.54	5.08
CD14+CD16+ Monocytes, donor3	11912-125G4	38.56	3.68	3.47
CD14+CD16- Monocytes, donor1	11788-124B6	34.57	4.67	8.25
CD14+CD16- Monocytes, donor2	11799-124C8	27.59	2.97	6.64
CD14+CD16- Monocytes, donor3	11910-125G2	26.09	3.34	8.03
CD14-CD16+ Monocytes, donor1	11790-124B8	32.66	4.08	2.81
CD14-CD16+ Monocytes, donor2	11800-124C9	23.71	3.95	3.07
CD14-CD16+ Monocytes, donor3	11911-125G3	32.00	2.74	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	60.97	12.19	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	53.56	5.42	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	8.28	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	68.76	8.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	55.21	8.58	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	51.94	7.02	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	47.85	8.63	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	52.73	3.95	1.32
CD19+ B Cells, donor1	11544-120B5	15.62	12.33	0.00
CD19+ B Cells, donor2	11624-122B4	21.76	6.53	1.45
CD19+ B Cells, donor3	11705-123B4	21.20	6.06	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	75.96	4.44	12.93
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	69.91	3.60	13.18
CD34+ Progenitors, donor1	11545-120B6	15.06	3.01	0.00
CD34+ Progenitors, donor2	11625-122B5	20.23	5.62	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	48.10	7.89	3.76
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	53.89	10.60	5.19
CD4+ T Cells, donor1	11225-116C1	36.06	8.21	1.07
CD4+ T Cells, donor2	11306-117C1	40.42	8.57	0.00
CD4+ T Cells, donor3	11382-118B5	28.36	7.01	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	47.47	2.55	15.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	49.86	2.92	10.33
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	49.16	3.45	15.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	59.26	7.59	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	69.53	7.73	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	36.26	9.89	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	36.13	3.90	15.90
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	42.37	2.37	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	43.69	2.58	2.42
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	46.17	3.59	7.62
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	46.82	3.49	6.64
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	36.96	4.40	7.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	40.06	2.53	10.54
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	47.79	2.49	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	51.79	2.00	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	44.87	7.34	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.92	4.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	53.80	10.76	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	45.99	4.26	17.62
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	39.86	3.03	9.96
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	42.87	2.31	10.93
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	54.10	5.06	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	47.22	6.93	4.77
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	31.81	3.92	2.61
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	76.21	6.93	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	64.62	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	80.96	9.77	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	53.72	6.37	2.49
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	52.76	4.17	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.52	2.86	2.86
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	78.94	4.15	0.00
CD8+ T Cells, donor1	11226-116C2	25.54	8.51	0.98
CD8+ T Cells, donor2	11307-117C2	23.65	7.88	0.38
CD8+ T Cells, donor3	11383-118B6	34.09	8.08	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	45.65	14.22	2.98
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	35.95	9.35	4.31
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	43.23	12.31	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	39.03	15.01	3.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	40.32	9.36	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	43.43	11.37	2.05
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	52.80	15.21	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	51.06	15.00	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	47.61	15.01	1.41
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	59.17	20.83	3.32
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	57.23	12.78	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	60.48	15.99	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	21.45	10.51	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.32	10.93	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	8.95	3.73
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	40.34	11.89	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	42.30	8.92	2.88
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	45.73	8.49	2.12
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	59.89	22.82	1.90
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	45.21	19.99	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	44.56	18.91	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	45.90	14.92	3.44
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	41.78	13.40	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	43.12	13.62	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.89	12.04	4.01
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	22.38	12.59	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	12.02	3.01
Cardiac Myocyte, donor1	11525-119I4	25.59	1.83	3.66
Cardiac Myocyte, donor2	11605-120I3	42.49	3.46	1.98
Cardiac Myocyte, donor3	11686-122I3	35.88	3.89	4.63
Chondrocyte - de diff, donor1	11261-116G1	41.25	3.12	5.55
Chondrocyte - de diff, donor2	11338-117F6	22.39	3.20	1.42
Chondrocyte - de diff, donor3	11410-118E6	20.59	2.16	0.91
Chondrocyte - re diff, donor2	11339-117F7	31.33	4.48	2.69
Chondrocyte - re diff, donor3	11411-118E7	26.69	3.64	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	42.35	6.08	9.75
Ciliary Epithelial Cells, donor2	11323-117D9	37.62	5.13	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	38.76	5.58	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	39.80	4.59	21.92
Corneal Epithelial Cells, donor1	11526-119I5	22.18	5.05	5.05
Corneal Epithelial Cells, donor2	11606-120I4	28.44	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	48.06	7.16	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	38.30	8.25	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	33.43	14.82	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	33.58	6.80	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	19.47	6.83	5.81
Dendritic Cells - plasmacytoid, donor2	11309-117C4	36.56	14.36	4.57
Dendritic Cells - plasmacytoid, donor3	11385-118B8	31.46	12.10	5.81
Endothelial Cells - Aortic, donor0	11207-116A1	52.53	6.67	4.00
Endothelial Cells - Aortic, donor1	11263-116G3	54.57	3.52	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	34.22	5.09	2.83
Endothelial Cells - Aortic, donor3	11412-118E8	48.75	4.72	1.18
Endothelial Cells - Artery, donor1	11264-116G4	31.71	3.78	0.29
Endothelial Cells - Artery, donor2	11341-117F9	33.88	8.00	2.12
Endothelial Cells - Artery, donor3	11413-118E9	55.75	8.94	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.91	4.88	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	25.56	4.56	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	19.17	2.54	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	35.36	2.67	3.27
Endothelial Cells - Microvascular, donor2	11342-117G1	39.57	6.77	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	27.79	3.40	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	44.41	9.60	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	37.74	3.14	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	61.13	10.93	8.08
Endothelial Cells - Umbilical vein, donor2	11324-117E1	58.01	9.34	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	62.16	8.30	0.73
Endothelial Cells - Vein, donor1	11267-116G7	56.88	7.96	1.14
Endothelial Cells - Vein, donor2	11344-117G3	46.10	8.38	16.76
Endothelial Cells - Vein, donor3	11416-118F3	51.81	6.59	0.63
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	1.65	4.95
Eosinophils, donor3	12246-129H5	3.57	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	26.39	4.89	3.66
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	31.20	1.64	1.64
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	19.27	2.74	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	44.31	1.95	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	35.90	3.52	1.58
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	14.60	3.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	26.47	0.95	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	18.97	3.69	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	42.85	2.99	0.33
Fibroblast - Cardiac, donor1	11268-116G8	40.83	3.18	0.91
Fibroblast - Cardiac, donor2	11345-117G4	31.08	6.06	4.55
Fibroblast - Cardiac, donor3	11417-118F4	30.91	3.63	0.79
Fibroblast - Cardiac, donor4	11452-119A3	26.37	2.12	5.46
Fibroblast - Cardiac, donor5	11456-119A7	36.93	3.93	0.38
Fibroblast - Cardiac, donor6	11460-119B2	50.03	2.27	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	30.55	3.89	5.76
Fibroblast - Choroid Plexus, donor2	11572-120E6	25.02	3.88	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	46.87	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	33.21	3.92	10.38
Fibroblast - Conjunctival, donor3	11692-122I9	22.56	2.20	8.65
Fibroblast - Dermal, donor1	11269-116G9	27.00	3.99	0.00
Fibroblast - Dermal, donor2	11346-117G5	59.43	6.60	5.66
Fibroblast - Dermal, donor3	11418-118F5	26.72	2.66	0.97
Fibroblast - Dermal, donor4	11450-119A1	36.51	3.50	1.13
Fibroblast - Dermal, donor5	11454-119A5	56.35	4.54	0.87
Fibroblast - Dermal, donor6	11458-119A9	51.65	4.06	1.46
Fibroblast - Gingival, donor1	11237-116D4	22.28	3.12	6.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	33.27	4.98	1.05
Fibroblast - Gingival, donor2	11318-117D4	39.80	3.43	0.92
Fibroblast - Gingival, donor3	11394-118C8	18.76	1.64	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	23.89	4.16	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.49	1.94	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.18	4.52	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	36.92	3.25	1.62
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	17.29	1.41	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	37.58	3.36	2.49
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	44.04	4.23	1.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	55.40	5.05	2.19
Fibroblast - Gingival, donor9 (control)	11927-125I1	23.77	1.17	1.76
Fibroblast - Lung, donor1	11270-116H1	20.39	1.36	4.08
Fibroblast - Lung, donor2	11347-117G6	26.86	4.48	8.95
Fibroblast - Lung, donor3	11419-118F6	37.35	5.28	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	26.66	2.50	14.16
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	13.15	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	28.01	2.84	14.21
Fibroblast - Mammary, donor2	11620-122A9	19.97	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	41.90	3.88	3.88
Fibroblast - Periodontal Ligament, donor2	11319-117D5	35.65	3.03	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	19.28	1.84	7.65
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	27.86	2.29	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	39.96	2.70	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	27.37	2.20	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	47.20	6.08	2.10
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	28.85	6.71	13.21
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	37.42	6.68	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	40.33	3.95	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	20.84	4.17	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	18.12	1.42	4.26
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	21.29	2.96	5.72
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.05	4.51	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	29.36	3.45	4.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.03	4.30	0.00
Fibroblast - skin normal, donor1	11553-120C5	22.97	1.80	6.23
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.06	4.21	0.80
Fibroblast - skin normal, donor2	11561-120D4	33.45	1.91	3.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	29.62	4.23	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	23.20	1.57	5.96
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	24.27	2.56	4.27
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.74	1.97	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	31.53	3.09	2.24
Fibroblast - skin walker warburg, donor1	11554-120C6	40.99	4.39	4.22
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	26.97	2.98	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	22.16	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	41.83	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	38.83	8.15	1.91
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	35.13	7.29	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	40.88	12.78	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	104.12	18.37	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	117.41	14.68	4.47
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	134.36	24.82	4.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	76.66	9.38	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	68.04	6.85	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	86.58	12.09	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	79.56	6.61	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	66.53	4.24	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.04	24.76	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	54.13	12.72	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	51.97	9.61	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	49.43	8.60	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	38.53	6.32	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	50.94	9.83	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	40.25	5.08	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	37.19	4.79	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	37.74	3.86	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.50	5.68	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	39.00	7.39	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	49.75	7.79	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	39.99	7.15	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.38	6.25	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	49.03	7.63	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	44.60	6.12	3.01
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	42.04	6.24	4.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.62	5.64	2.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	48.47	5.31	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.60	6.49	2.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	38.39	7.96	3.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	38.17	5.98	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	45.08	4.61	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	39.02	6.17	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	41.66	3.97	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	42.68	6.52	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	41.66	6.48	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.32	5.45	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	43.02	4.55	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	39.86	3.48	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.88	6.08	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.71	7.00	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.79	5.71	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	36.19	3.37	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	40.65	4.26	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	46.80	6.15	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	35.50	3.98	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	42.62	7.12	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	50.15	6.23	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	33.00	4.61	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	28.29	3.07	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	27.77	0.99	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	27.97	4.09	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.42	3.83	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	15.76	1.78	3.30
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	53.95	14.93	6.57
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	52.39	11.56	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	64.03	15.75	1.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	81.67	21.28	4.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	91.83	17.80	9.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	59.96	8.30	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	22.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	70.40	15.09	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	83.43	16.04	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	79.99	17.39	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.17	16.92	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	71.24	12.35	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	16.66	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.05	10.91	4.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	60.14	11.77	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	49.49	7.55	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	66.48	11.13	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	57.74	10.87	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	98.14	14.62	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	75.02	10.88	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	63.93	8.29	2.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	76.24	16.94	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	68.34	17.40	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	64.67	17.26	2.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	73.76	10.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	54.20	6.54	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	57.37	6.19	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	89.62	11.37	6.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	59.33	10.40	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	51.01	23.62	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	2.48	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	56.15	7.55	1.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	60.95	9.66	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	64.09	6.61	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	52.65	9.97	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	57.23	10.36	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	48.40	20.07	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	71.18	8.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	43.89	7.90	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	42.38	11.87	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	59.69	8.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	64.54	14.07	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	23.29	2.91	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	49.48	5.62	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.96	2.54	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	19.63	1.25	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	101.42	17.64	2.09
Hep-2 cells mock treated, biol_rep2	11899-125E9	86.76	21.44	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	84.63	17.75	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	96.30	16.94	2.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	86.39	17.84	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	82.67	16.79	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	94.03	17.81	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	78.40	20.24	1.20
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	82.98	20.82	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	49.25	7.83	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.80	2.16	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	41.62	7.41	4.23
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	27.61	4.36	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	40.74	7.52	1.05
Hepatocyte, donor1	11523-119I2	47.21	2.42	0.00
Hepatocyte, donor2	11603-120I1	36.63	5.39	0.00
Hepatocyte, donor3	11684-122I1	50.31	7.98	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	45.69	13.71	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	70.44	12.23	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.16	4.12	6.04
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	15.92	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	13.35	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	27.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	45.68	11.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	35.04	15.02	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	25.63	10.25
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	18.28	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	40.61	29.24	11.37
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	65.02	18.34	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	10.89	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	62.20	37.06	14.56
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	55.43	18.85	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	15.71	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	50.39	11.97	6.30
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	57.23	21.65	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	57.50	18.09	6.46
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	49.91	12.88	8.05
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	11.95	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	70.89	8.15	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	54.16	22.25	24.77
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	48.22	16.88	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	59.09	22.16	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	53.81	21.24	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	39.91	14.51	7.26
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	48.43	18.29	8.61
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	58.44	24.14	5.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.10	17.86	7.01
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	47.39	29.16	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	56.41	19.28	7.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	82.96	26.55	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	58.03	20.37	2.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	22.83	8.78
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	50.29	31.43	9.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	48.68	20.86	3.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	6.64	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	25.94	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	40.98	6.10	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	20.25	15.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	10.45	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	50.14	12.80	6.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	47.11	15.24	20.78
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	14.25	5.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	59.83	9.20	4.60
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	3.03	12.10
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	32.78	7.40	7.40
Keratinocyte - epidermal, donor1	11272-116H3	20.64	4.73	1.71
Keratinocyte - epidermal, donor2	11349-117G8	31.04	4.69	4.10
Keratinocyte - epidermal, donor3	11421-118F8	48.56	5.68	0.95
Keratinocyte - oral, donor1	11251-116E9	39.96	4.09	5.22
Keratocytes, donor1	11527-119I6	35.07	6.53	6.19
Keratocytes, donor2	11607-120I5	43.36	5.86	0.00
Keratocytes, donor3	11688-122I5	31.81	2.17	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	52.75	8.79	2.20
Lens Epithelial Cells, donor1	11529-119I8	37.76	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	31.95	4.61	6.57
Lens Epithelial Cells, donor3	11690-122I7	22.30	2.83	3.43
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	40.67	5.69	3.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	47.72	4.74	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	41.71	5.04	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	35.49	5.38	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	43.81	4.41	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	47.44	4.74	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.29	7.39	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	45.25	7.84	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	40.82	5.91	1.41
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	29.27	2.77	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	47.89	9.50	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	38.70	5.37	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	36.58	5.57	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	42.93	5.72	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	41.89	6.46	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	31.10	7.70	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	44.89	3.12	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	39.16	4.03	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	37.85	4.94	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	45.40	7.32	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	43.81	3.73	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.37	5.33	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	45.78	8.62	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	48.29	5.00	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	38.36	6.22	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.55	7.96	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	45.26	4.36	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	31.64	8.94	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	46.10	9.03	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	41.46	5.73	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	31.98	6.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	45.98	5.29	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	41.01	5.82	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	37.02	5.55	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.50	6.67	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	41.94	4.81	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.38	3.22	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.65	10.35	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	45.07	5.04	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	40.18	5.69	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	53.33	12.12	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	39.84	5.76	1.24
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	40.11	7.52	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	52.92	9.15	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	40.49	4.00	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	37.99	3.59	3.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	40.72	7.68	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	36.70	6.56	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	54.38	6.80	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	50.63	9.97	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	50.47	12.62	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	44.43	8.89	4.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	53.45	8.44	3.52
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	7.47	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	42.25	12.88	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	35.68	8.33	8.33
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	49.31	9.27	11.08
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	41.01	10.18	3.20
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	45.02	10.80	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	46.20	12.60	13.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	43.65	10.27	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.17	11.64	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	35.98	6.66	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	42.79	8.15	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	55.23	12.81	1.07
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	53.47	12.28	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	55.83	8.59	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	56.26	15.49	6.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	46.23	10.41	2.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	55.49	12.05	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	40.18	8.24	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	51.38	7.55	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	52.61	12.85	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	42.05	7.75	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	37.47	8.48	4.60
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	43.15	5.90	2.21
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	6.91	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	50.27	12.28	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	43.03	5.66	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	48.41	8.20	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	49.26	11.75	6.33
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	42.37	4.31	2.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	50.04	14.19	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	44.22	13.01	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	41.35	5.17	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	45.38	10.28	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	54.31	10.33	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	46.45	9.05	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	44.08	6.40	2.13
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	41.25	7.22	7.91
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	40.26	12.35	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	41.75	11.45	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	38.15	10.00	4.44
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	61.64	4.65	9.30
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	44.43	9.52	5.29
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	45.22	10.00	4.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	47.97	7.27	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	62.85	13.03	10.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	50.31	10.36	8.39
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	36.70	16.00	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	41.23	9.55	4.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	37.40	9.91	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	8.61	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	56.11	12.91	4.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	42.62	10.56	3.91
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	44.86	7.26	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	42.55	14.01	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	46.38	10.06	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	43.05	11.74	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	48.58	9.72	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	54.00	11.57	3.47
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.58	9.11	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	43.74	12.02	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	49.69	9.94	4.37
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.28	10.94	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	42.19	3.46	3.46
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.44	10.26	3.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	54.22	12.39	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	33.26	5.44	2.42
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	48.49	13.94	3.17
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	48.51	9.60	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	46.55	8.62	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	49.37	10.28	6.69
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	48.81	9.20	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	55.61	9.65	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	38.27	6.24	4.58
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	4.70	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	41.75	10.02	3.34
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	49.72	10.22	3.25
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	43.49	5.35	3.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	49.19	10.16	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	47.28	10.91	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	44.97	8.26	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	48.01	8.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	49.58	9.69	2.85
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	49.08	6.90	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	44.87	4.92	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	40.98	8.91	4.01
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	61.87	8.06	14.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	49.07	7.96	2.65
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	6.24	6.24
Macrophage - monocyte derived, donor1	11232-116C8	31.91	4.56	0.68
Macrophage - monocyte derived, donor2	11313-117C8	46.79	9.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	43.39	9.31	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	57.35	15.93	0.53
Mallassez-derived cells, donor2	11929-125I3	33.12	6.50	2.06
Mallassez-derived cells, donor3	11930-125I4	42.53	7.64	2.08
Mammary Epithelial Cell, donor1	11273-116H4	46.23	4.68	3.89
Mammary Epithelial Cell, donor2	11350-117G9	34.46	7.24	1.45
Mammary Epithelial Cell, donor3	11422-118F9	40.41	7.48	0.25
Mast cell - stimulated, donor1	11487-119E2	24.41	2.03	5.42
Mast cell, donor1	11563-120D6	25.63	1.62	4.76
Mast cell, donor2	11565-120D8	12.48	1.49	0.00
Mast cell, donor3	11566-120D9	21.84	0.90	0.00
Mast cell, donor4	11567-120E1	20.74	1.77	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	30.83	2.55	3.44
Mast cell, expanded and stimulated, donor8	11942-126A7	29.77	3.50	4.09
Mast cell, expanded, donor5	11939-126A4	35.10	1.95	2.52
Mast cell, expanded, donor8	11941-126A6	23.93	3.18	2.34
Melanocyte - dark, donor1	11502-119F8	43.78	5.87	7.76
Melanocyte - dark, donor2	11582-120F7	42.22	3.46	2.42
Melanocyte - dark, donor3	11663-122F7	45.86	5.00	1.45
Melanocyte - light, donor1	11274-116H5	23.74	1.88	1.65
Melanocyte - light, donor2	11351-117H1	29.35	1.36	5.46
Melanocyte - light, donor3	11423-118G1	34.69	3.47	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	42.90	6.46	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	44.64	5.38	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	31.07	2.95	0.80
Meningeal Cells, donor1	11493-119E8	38.46	7.07	9.80
Meningeal Cells, donor2	11573-120E7	58.10	3.96	0.88
Meningeal Cells, donor3	11654-122E7	40.34	4.48	6.93
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.91	5.99	3.99
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	18.11	3.12	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63	17.08
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	18.31	9.16	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	53.82	6.46	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.97	2.75	3.60
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	38.20	5.03	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	35.82	5.27	5.27
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	51.87	10.96	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	38.47	4.30	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.61	2.35	3.32
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.61	2.23	5.58
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	26.18	2.63	5.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.87	2.08	9.20
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	41.63	3.20	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	57.07	7.44	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	30.02	5.00	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	63.14	8.71	0.73
Mesothelial Cells, donor1	11247-116E5	31.56	4.77	0.27
Mesothelial Cells, donor2	12156-128G5	33.03	2.00	0.00
Mesothelial Cells, donor3	11402-118D7	28.40	3.97	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	25.66	14.85	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.31	9.85	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	43.29	11.78	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	42.15	7.13	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	39.00	10.37	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.79	7.51	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	43.76	15.83	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.50	7.93	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	38.41	11.88	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	16.81	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	40.65	11.02	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	7.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	28.23	5.94	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	32.23	7.37	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	17.29	7.45	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	8.38	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	21.83	6.27	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	29.95	8.79	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.88	1.11	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	21.18	7.37	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.35	7.15	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	19.98	4.89	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.60	6.22	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	26.67	7.78	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	16.43	4.38	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.72	5.58	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	31.48	6.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	16.85	5.71	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	21.76	9.70	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	17.78	2.88	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	26.42	5.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	21.52	5.01	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	18.83	2.63	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	19.87	2.21	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	23.05	6.40	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	24.30	7.69	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	5.57	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	6.63	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	18.80	5.47	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	10.07	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	14.20	5.33	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.21	7.01	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.52	8.31	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	5.83	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	23.53	4.52	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	29.63	8.77	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	16.62	3.69	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	33.58	7.97	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	17.55	3.45	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	21.77	5.44	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.16	8.58	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.79	3.18	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	16.55	4.54	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	30.53	11.67	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	16.39	3.11	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	23.25	5.73	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	32.95	11.94	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	15.93	3.79	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.44	10.23	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	32.45	7.62	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.85	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.05	8.23	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	28.26	12.40	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	18.13	5.36	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.72	5.96	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	15.07	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	8.91	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	39.76	5.91	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	45.23	4.21	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.13	7.71	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	37.25	12.11	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	45.44	3.76	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	37.02	6.66	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	35.06	8.93	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.05	6.63	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	41.04	9.16	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	21.78	7.78	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	35.27	6.41	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	34.34	5.05	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.26	6.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	21.79	5.45	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.17	1.27	5.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	17.01	0.81	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	13.05	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	29.95	5.39	1.29
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	31.88	4.18	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.03	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	16.28	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	47.16	2.66	1.33
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	52.66	6.38	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	12.92	0.00	1.36
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	5.51	9.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	16.74	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.01	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	12.97	1.08	1.89
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	17.03	2.31	2.31
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	16.88	2.48	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.71	1.35	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	13.15	0.45	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.15	0.98	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.05	1.46	0.73
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	1.59	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	9.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	24.29	2.95	3.61
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	9.43	0.98	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	19.75	1.59	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	14.71	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.14	1.93	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	21.38	2.07	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	32.87	0.00	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.16	1.56	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	16.09	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	16.14	0.95	1.42
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.31	1.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	0.00	27.08
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	22.09	2.25	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.68	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	12.07	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.81	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	8.80	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.89	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	8.82	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	11.41	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	12.63	1.53	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	30.24	1.21	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	24.75	3.76	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	1.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	1.57	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.32	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	13.45	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	18.14	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	5.06	0.00
Myoblast, donor1	11241-116D8	24.47	4.10	1.49
Myoblast, donor2	11322-117D8	29.54	3.84	0.96
Myoblast, donor3	11398-118D3	29.60	3.36	2.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	28.02	4.09	2.19
Natural Killer Cells, donor1	11230-116C6	25.83	8.30	0.62
Natural Killer Cells, donor2	11311-117C6	20.81	7.24	0.30
Natural Killer Cells, donor3	11387-118C1	20.98	9.94	0.18
Neural stem cells, donor1	11275-116H6	42.83	3.63	11.98
Neural stem cells, donor2	11352-117H2	21.18	5.78	7.70
Neurons, donor1	11494-119E9	46.65	9.10	2.28
Neurons, donor2	11574-120E8	43.59	5.50	3.74
Neurons, donor3	11655-122E8	61.66	1.64	1.64
Neutrophils, donor1	11233-116C9	0.00	0.00	17.63
Neutrophils, donor2	11314-117C9	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	1.22	1.22	17.10
Nucleus Pulposus Cell, donor1	11252-116F1	20.78	1.78	8.19
Nucleus Pulposus Cell, donor2	11409-118E5	24.42	1.30	1.63
Nucleus Pulposus Cell, donor3	11462-119B4	32.69	2.01	0.00
Olfactory epithelial cells, donor1	11933-125I7	24.50	1.79	0.83
Olfactory epithelial cells, donor2	11934-125I8	31.84	3.47	2.03
Olfactory epithelial cells, donor3	11935-125I9	36.78	3.06	1.59
Olfactory epithelial cells, donor4	11936-126A1	25.52	2.53	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	48.15	4.81	1.81
Osteoblast - differentiated, donor1	11276-116H7	18.29	3.40	0.43
Osteoblast - differentiated, donor2	11353-117H3	26.29	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.76	3.72	1.24
Osteoblast, donor1	11277-116H8	57.26	6.25	20.33
Osteoblast, donor2	11354-117H4	30.90	3.51	3.51
Osteoblast, donor3	11426-118G4	55.10	4.44	0.53
Pancreatic stromal cells, donor1	11249-116E7	25.02	2.95	3.79
Pericytes, donor1	11491-119E6	17.25	1.45	8.90
Pericytes, donor2	11571-120E5	22.18	3.62	0.68
Pericytes, donor3	11652-122E5	39.27	4.27	0.61
Perineurial Cells, donor1	11499-119F5	31.99	3.05	3.84
Perineurial Cells, donor2	11579-120F4	39.01	4.05	8.19
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.32	2.87	2.87
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	20.32	2.69	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	19.28	3.88	0.26
Placental Epithelial Cells, donor1	11278-116H9	53.57	8.85	1.20
Placental Epithelial Cells, donor2	11355-117H5	48.79	7.76	4.44
Placental Epithelial Cells, donor3	11427-118G5	32.79	4.91	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	28.16	1.90	0.63
Preadipocyte - breast, donor1	11467-119B9	22.32	2.63	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	14.36	3.65	0.26
Preadipocyte - breast, donor2	11328-117E5	34.22	3.83	0.00
Preadipocyte - omental, donor1	11468-119C1	21.74	2.88	0.96
Preadipocyte - omental, donor2	11329-117E6	30.55	3.93	0.87
Preadipocyte - omental, donor3	11403-118D8	31.23	3.01	0.29
Preadipocyte - perirenal, donor1	11469-119C2	33.47	7.87	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	46.07	3.99	10.75
Preadipocyte - subcutaneous, donor2	11356-117H6	55.60	4.07	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	45.81	4.60	0.68
Preadipocyte - visceral, donor1	11280-116I2	41.73	3.26	6.33
Preadipocyte - visceral, donor2	11357-117H7	35.89	1.38	1.84
Preadipocyte - visceral, donor3	11429-118G7	52.45	3.66	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	55.66	13.28	3.17
Prostate Epithelial Cells, donor2	11331-117E8	24.51	4.06	0.14
Prostate Epithelial Cells, donor3	11404-118D9	29.88	4.16	0.43
Prostate Stromal Cells, donor1	11254-116F3	43.28	7.18	2.73
Prostate Stromal Cells, donor2	11332-117E9	51.46	4.30	0.90
Prostate Stromal Cells, donor3	11405-118E1	31.80	1.98	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	35.77	6.93	5.84
Renal Cortical Epithelial Cells, donor2	11596-120H3	38.05	5.68	2.63
Renal Epithelial Cells, donor1	11517-119H5	21.81	5.58	10.65
Renal Epithelial Cells, donor2	11597-120H4	43.39	7.82	0.00
Renal Epithelial Cells, donor3	11678-122H4	37.90	6.14	3.39
Renal Glomerular Endothelial Cells, donor1	11514-119H2	41.53	6.13	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	55.93	7.28	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	48.40	6.66	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.98	2.00	2.00
Renal Mesangial Cells, donor1	11518-119H6	35.65	7.48	8.36
Renal Mesangial Cells, donor2	11598-120H5	45.14	3.76	0.63
Renal Mesangial Cells, donor3	11679-122H5	30.79	4.72	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	42.41	9.93	4.29
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	34.58	10.96	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	56.89	6.56	1.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	61.71	10.63	5.96
Retinal Pigment Epithelial Cells, donor1	11528-119I7	33.83	7.67	4.55
Retinal Pigment Epithelial Cells, donor2	11608-120I6	37.05	10.29	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	28.85	4.01	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	37.28	3.34	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	63.43	4.47	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	28.07	15.41	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	41.18	8.12	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	70.47	15.34	3.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	82.32	12.81	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	81.31	17.62	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	80.88	18.23	2.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	76.69	11.89	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	78.58	11.33	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	64.35	11.91	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	71.25	11.35	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	99.63	16.13	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	69.72	14.92	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	75.66	12.77	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	86.07	10.84	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	62.13	9.56	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	76.39	13.79	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	73.47	12.59	4.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	71.40	14.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	79.43	13.34	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	79.44	13.94	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	69.31	11.85	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	66.43	14.30	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	78.61	14.36	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	67.83	15.13	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	73.70	13.12	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	86.77	19.61	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	68.17	15.33	1.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	78.57	10.71	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	80.91	14.73	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	75.68	13.89	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	73.66	15.48	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	73.74	14.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	76.31	12.52	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	81.57	17.20	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	80.78	13.11	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	75.48	15.65	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	93.00	14.40	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	87.83	13.46	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	64.25	14.49	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	97.06	13.17	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	57.31	10.93	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	54.75	8.71	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	77.38	12.86	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	61.87	10.28	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	51.04	9.98	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	50.31	9.78	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	55.31	6.95	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	57.40	10.65	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	59.09	13.68	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	64.49	14.60	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	53.35	12.06	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.95	7.69	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	46.43	11.98	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	50.77	10.15	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.12	11.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	49.28	12.02	0.00
Schwann Cells, donor1	11498-119F4	42.13	4.14	0.75
Schwann Cells, donor2	11578-120F3	34.02	0.00	0.00
Schwann Cells, donor3	11659-122F3	36.59	3.51	0.66
Sebocyte, donor1	11220-116B5	32.32	3.83	3.29
Sebocyte, donor2	11301-117B5	28.95	5.06	0.46
Sebocyte, donor3	11378-118B1	24.53	3.71	1.03
Sertoli Cells, donor1	11255-116F4	36.45	9.94	0.00
Sertoli Cells, donor2	11333-117F1	25.42	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	29.91	2.99	8.89
Skeletal Muscle Cells, donor2	11358-117H8	19.52	3.61	1.45
Skeletal Muscle Cells, donor3	11430-118G8	65.21	8.36	0.84
Skeletal Muscle Cells, donor4	11451-119A2	61.89	8.17	0.79
Skeletal Muscle Cells, donor5	11455-119A6	62.13	5.80	0.45
Skeletal Muscle Cells, donor6	11459-119B1	66.18	6.00	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	30.12	2.39	3.91
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.10	4.99	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	54.86	8.33	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	33.36	4.30	8.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	44.15	5.79	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	39.63	3.58	0.83
Skin - palm, donor1	10286-104F7	29.55	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.78	4.61	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	19.63	10.63	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.41	4.02	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	25.30	5.14	2.22
Small Airway Epithelial Cells, donor2	11334-117F2	30.52	2.39	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.87	12.48	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	27.81	4.27	0.97
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	33.33	2.16	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.56	1.78	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	43.50	1.76	5.29
Smooth Muscle Cells - Aortic, donor1	11283-116I5	28.95	2.87	5.08
Smooth Muscle Cells - Aortic, donor2	11360-117I1	48.43	5.12	1.97
Smooth Muscle Cells - Aortic, donor3	11432-118H1	43.26	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	38.03	2.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	29.54	2.79	2.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	31.92	4.43	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	54.16	3.20	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	41.68	4.56	3.91
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	34.26	3.54	2.95
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	32.89	2.56	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	26.03	2.11	6.18
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.35	1.22	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	41.17	1.26	12.12
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	36.72	3.34	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.07	3.10	3.39
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.64	4.95	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	43.35	6.30	0.63
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	53.98	5.26	2.32
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	63.59	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	49.61	3.29	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.34	5.46	6.15
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.03	2.12	4.32
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	23.45	2.01	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	33.91	3.64	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	36.23	3.02	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	70.47	12.72	7.95
Smooth Muscle Cells - Prostate, donor1	11257-116F6	39.81	3.73	2.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	38.32	2.50	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.84	1.78	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	37.24	2.86	4.22
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	30.01	4.50	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	78.83	5.17	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	45.58	3.26	4.19
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	31.81	4.54	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	28.83	4.70	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.42	1.18	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	45.90	5.17	4.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.23	0.47	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	36.56	4.75	3.02
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	47.68	4.33	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	51.33	3.95	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.68	4.89	6.01
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.48	3.44	3.77
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	15.71	2.38	1.43
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	35.97	4.65	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	41.98	3.98	2.43
Smooth Muscle Cells - Uterine, donor3	11466-119B8	38.91	3.22	11.12
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	18.27	1.94	2.14
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	20.10	2.64	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	14.51	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	16.53	1.80	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.38	3.41	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.51	5.51	2.76
Smooth muscle cells - airway, control, donor1	11966-126D4	14.48	1.78	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	10.38	2.00	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	22.57	2.51	2.93
Smooth muscle cells - airway, control, donor4	11969-126D7	30.25	2.29	2.75
Synoviocyte, donor1	11291-117A4	25.08	3.37	4.21
Synoviocyte, donor2	11368-117I9	22.63	2.68	0.50
Synoviocyte, donor3	11440-118H9	21.89	2.01	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	42.17	4.65	9.29
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	3.96	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	20.61	2.55	1.62
Tracheal Epithelial Cells, donor1	11292-117A5	49.39	5.66	6.09
Tracheal Epithelial Cells, donor2	11369-118A1	30.93	7.73	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	34.93	7.44	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	38.14	3.08	0.98
Urethra, donor2	10319-105A4	19.78	0.00	0.00
Urothelial Cells, donor1	11520-119H8	24.71	6.91	1.59
Urothelial Cells, donor2	11600-120H7	26.04	4.01	0.40
Urothelial Cells, donor3	11681-122H7	26.59	5.50	0.00
Urothelial cells, donor0	11216-116B1	27.64	3.79	2.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	28.47	4.45	100.55
Whole blood (ribopure), donor090309, donation2	12180-129A2	42.89	1.43	82.92
Whole blood (ribopure), donor090309, donation3	12181-129A3	16.43	1.37	19.17
Whole blood (ribopure), donor090325, donation1	12176-128I7	24.10	2.75	64.74
Whole blood (ribopure), donor090325, donation2	12177-128I8	24.98	1.74	61.01
Whole blood (ribopure), donor090612, donation1	12182-129A4	14.58	1.04	73.93
Whole blood (ribopure), donor090612, donation2	12183-129A5	25.70	3.67	68.83
Whole blood (ribopure), donor090612, donation3	12184-129A6	19.17	0.00	21.00
Wilms' tumor cell line:G-401	10809-111A8	68.47	10.36	0.62
Wilms' tumor cell line:HFWT	10597-108E3	46.64	3.52	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	67.04	8.10	2.23
achilles tendon, donor2	10292-104G4	35.13	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	71.13	19.12	5.61
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	63.85	13.00	12.77
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	38.58	9.02	10.92
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	96.06	21.22	7.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	80.11	9.84	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	89.46	12.27	8.04
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	31.03	4.63	2.99
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	45.39	11.90	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	53.90	7.35	5.72
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	76.49	17.47	3.49
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	81.33	15.82	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.58	12.55	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	56.18	17.09	3.11
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	62.83	15.20	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	30.67	3.25	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.89	3.70	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	47.88	5.83	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	74.25	7.25	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	51.86	13.95	3.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	51.51	13.48	4.33
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	58.13	10.02	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	44.03	10.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	92.91	22.30	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	75.33	10.55	1.51
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	42.30	10.03	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	11.25	3.75
adenocarcinoma cell line:IM95m	10796-110I4	58.87	9.18	0.94
adipose tissue, adult, pool1	10010-101C1	23.58	3.88	0.31
adipose, donor1	10184-103D4	92.07	18.18	4.10
adipose, donor2	10185-103D5	38.52	2.03	2.03
adipose, donor3	10186-103D6	57.45	4.90	3.27
adipose, donor4	10187-103D7	78.01	12.13	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	69.28	4.42	2.21
adrenal gland, adult, pool1	10081-102A9	29.10	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	28.55	7.74	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	61.81	8.93	2.50
amniotic membrane cells, donor1	12235-129G3	32.23	5.10	0.00
amniotic membrane cells, donor2	12236-129G4	45.31	8.11	1.35
amniotic membrane cells, donor3	12237-129G5	38.00	5.30	0.00
amygdala - adult, donor10196	10167-103B5	27.27	3.56	0.00
amygdala, adult, donor10252	10151-102I7	33.66	4.26	0.00
amygdala, newborn, donor10223	10360-105E9	20.98	1.61	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	29.80	4.07	3.82
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	71.92	8.82	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	62.46	6.35	0.33
aorta, adult, pool1	10052-101G7	23.73	0.39	0.00
appendix, adult	10189-103D9	43.08	6.60	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	43.68	15.48	2.41
artery, adult	10190-103E1	84.24	9.51	0.00
astrocytoma cell line:TM-31	10425-106D2	41.87	5.79	3.33
b cell line:RPMI1788	10427-106D4	37.18	6.54	5.80
basal cell carcinoma cell line:TE 354.T	10702-109G9	34.68	1.39	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	44.16	11.41	4.37
bile duct carcinoma cell line:TFK-1	10496-107C1	76.99	14.73	6.19
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	35.23	2.24	1.68
bladder, adult, pool1	10011-101C2	21.73	0.87	0.65
blood, adult, pool1	10053-101G8	19.93	0.00	17.72
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	2.57	8.56
bone marrow, adult	10192-103E3	45.21	4.05	0.67
brain, adult, donor1	10084-102B3	50.23	1.03	0.00
brain, adult, pool1	10012-101C3	36.64	3.34	0.11
brain, fetal, pool1	10085-102B4	56.10	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	51.54	6.28	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	141.80	15.60	40.57
breast, adult, donor1	10080-102A8	22.10	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	79.27	6.86	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	101.42	7.11	5.88
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	39.37	10.59	5.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	67.78	12.10	1.45
carcinoid cell line:NCI-H1770	10703-109H1	55.01	9.87	1.41
carcinoid cell line:NCI-H727	10735-110B6	15.09	2.95	1.31
carcinoid cell line:SK-PN-DW	10719-109I8	53.24	6.65	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.97	11.18	1.06
caudate nucleus - adult, donor10196	10177-103C6	40.30	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	33.30	3.18	0.00
caudate nucleus, adult, donor10258	10379-105H1	48.14	3.06	0.00
caudate nucleus, newborn, donor10223	10354-105E3	30.76	3.30	0.37
cerebellum - adult, donor10196	10173-103C2	72.83	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	26.26	5.12	0.21
cerebellum, adult, pool1	10083-102B2	53.47	2.07	0.00
cerebellum, newborn, donor10223	10357-105E6	31.55	4.15	0.83
cerebral meninges, adult	10188-103D8	52.70	4.79	0.25
cerebrospinal fluid, donor2	10294-104G6	67.97	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	69.16	12.37	4.17
cervical cancer cell line:ME-180	10553-107I4	56.34	8.95	5.97
cervix, adult, pool1	10013-101C4	28.66	1.57	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	36.92	9.61	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	3.92	0.00
choriocarcinoma cell line:BeWo	10423-106C9	63.63	22.37	2.98
choriocarcinoma cell line:SCH	10785-110H2	47.93	11.95	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	81.11	31.07	0.47
chorionic membrane cells, donor1	12238-129G6	27.35	4.27	0.00
chorionic membrane cells, donor2	12239-129G7	38.28	4.67	1.49
chorionic membrane cells, donor3	12240-129G8	30.77	3.30	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	59.58	16.16	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.41	6.72	3.46
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	47.52	2.53	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	50.33	8.47	2.31
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	52.00	11.13	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	45.20	10.38	2.24
chronic myelogenous leukemia cell line:K562	10454-106G4	93.64	20.02	5.30
chronic myelogenous leukemia cell line:KU812	10409-106B4	69.33	11.99	29.71
clear cell carcinoma cell line:JHOC-5	10638-108I8	80.23	8.23	1.37
clear cell carcinoma cell line:TEN	10636-108I6	41.64	13.01	10.41
colon carcinoma cell line:CACO-2	10513-107D9	102.69	21.05	5.67
colon carcinoma cell line:COLO-320	10420-106C6	66.13	12.92	4.56
colon, adult, donor1	10082-102B1	60.69	8.33	0.00
colon, adult, pool1	10014-101C5	49.00	3.76	2.00
colon, fetal, donor1	10070-101I7	27.19	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	61.62	18.70	14.02
cord blood derived cell line:COBL-a 24h infection	10453-106G3	72.45	14.04	11.47
cord blood derived cell line:COBL-a untreated	10449-106F8	84.89	16.78	14.10
corpus callosum, adult, pool1	10042-101F6	34.50	3.98	0.33
cruciate ligament, donor2	10295-104G7	24.31	4.05	1.62
diaphragm, fetal, donor1	10069-101I6	79.45	4.01	0.80
diencephalon, adult	10193-103E4	34.56	5.28	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	47.76	6.89	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	87.96	11.54	5.13
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.53	6.74	4.33
ductus deferens, adult	10196-103E7	35.88	4.98	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	28.80	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	38.99	2.94	0.00
dura mater, adult, donor1	10041-101F5	25.44	1.82	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	45.52	57.29	7.99
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	66.06	36.68	10.03
embryonic pancreas cell line:1B2C6	10604-108F1	41.31	4.32	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	36.02	7.87	1.51
embryonic pancreas cell line:1C3IKEI	10606-108F3	46.00	7.41	2.16
embryonic pancreas cell line:2C6	10603-108E9	43.34	6.57	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	88.16	14.08	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	51.11	4.53	2.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	62.56	7.88	0.64
epidermoid carcinoma cell line:A431	10426-106D3	44.13	9.45	5.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	48.72	12.54	6.05
epididymis, adult	10197-103E8	33.91	2.72	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	38.68	8.34	2.84
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	28.31	5.90	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	72.60	15.46	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	56.10	13.29	2.17
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	79.32	14.56	1.57
esophagus, adult, pool1	10015-101C6	37.27	3.08	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	34.82	3.26	9.14
eye - muscle inferior rectus, donor1	10272-104E2	57.95	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	119.94	0.00	0.00
eye - muscle medial, donor2	10299-104H2	95.25	5.95	0.00
eye - muscle superior, donor2	10297-104G9	48.15	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	1.46	1.46
eye, fetal, donor1	10054-101G9	43.98	1.78	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	29.62	5.39	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	62.20	7.12	0.95
frontal lobe, adult, pool1	10040-101F4	39.41	3.57	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	78.97	13.21	5.10
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.40	8.23	2.19
gall bladder, adult	10198-103E9	38.63	2.41	0.00
gamma delta positive T cells, donor1	11937-126A2	39.73	6.44	0.54
gamma delta positive T cells, donor2	11938-126A3	33.99	4.86	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	21.12	6.55	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	52.80	10.25	0.58
gastric cancer cell line:AZ521	10549-107H9	102.96	22.63	14.10
gastric cancer cell line:GSS	10560-108A2	66.81	7.32	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	31.76	8.22	0.23
giant cell carcinoma cell line:LU65	10487-107B1	24.90	4.93	2.41
giant cell carcinoma cell line:Lu99B	10433-106E1	40.03	8.96	4.06
glassy cell carcinoma cell line:HOKUG	10688-109F4	54.37	4.74	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	40.53	6.54	2.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	43.26	5.76	3.09
glioblastoma cell line:T98G	10485-107A8	55.41	4.97	6.18
glioma cell line:GI-1	10413-106B8	29.58	6.15	4.98
globus pallidus - adult, donor10196	10175-103C4	40.09	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	27.34	3.91	0.00
globus pallidus, adult, donor10258	10367-105F7	36.97	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	36.24	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	56.28	24.47	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	88.85	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.04	3.20	0.00
hIPS +CCl2, biol_rep1	14383-156B9	39.94	15.15	3.67
hIPS +CCl2, biol_rep2	14384-156C1	27.44	12.80	2.74
hIPS +CCl2, biol_rep3	14385-156C2	34.14	16.10	1.93
hIPS, biol_rep1	14380-156B6	12.94	23.00	1.44
hIPS, biol_rep2	14381-156B7	28.12	11.66	5.49
hIPS, biol_rep3	14382-156B8	30.90	7.72	0.00
hairy cell leukemia cell line:Mo	10712-109I1	52.01	9.77	1.44
heart - mitral valve, adult	10205-103F7	49.93	2.39	0.00
heart - pulmonic valve, adult	10206-103F8	71.64	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	45.80	2.50	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	70.81	3.88	0.41
heart, adult, diseased, donor1	10051-101G6	93.68	5.11	0.43
heart, adult, pool1	10016-101C7	127.64	6.21	0.46
heart, fetal, pool1	10046-101G1	62.43	5.54	2.05
hepatic mesenchymal tumor cell line:LI90	10778-110G4	35.79	2.78	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	34.49	13.08	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	80.44	22.21	2.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	86.90	25.12	2.79
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	77.91	21.32	3.03
hepatoma cell line:Li-7	10484-107A7	69.73	11.68	5.12
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	67.74	8.74	1.41
hippocampus - adult, donor10196	10169-103B7	35.01	3.79	0.00
hippocampus, adult, donor10252	10153-102I9	31.64	6.12	0.20
hippocampus, adult, donor10258	10374-105G5	18.42	1.49	0.50
hippocampus, newborn, donor10223	10363-105F3	27.85	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	92.77	32.35	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	75.01	14.33	1.57
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	89.88	12.19	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	69.36	7.89	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	65.84	7.49	3.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	75.16	7.97	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.47	7.30	4.09
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	50.84	5.17	3.02
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	60.48	6.67	4.17
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	74.83	9.95	12.55
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	65.41	5.79	2.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	84.84	12.79	10.77
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	62.44	13.61	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	56.50	11.30	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	82.91	20.07	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	64.91	8.21	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	56.25	10.03	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	59.97	6.00	8.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	40.69	2.26	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	32.74	2.73	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	54.19	2.51	2.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.50	4.57	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.58	3.48	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	56.20	2.69	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	74.08	14.04	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	56.77	13.69	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	109.02	25.72	2.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	55.63	7.75	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	46.88	8.87	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	64.46	8.78	4.24
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.09	4.14	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	53.80	3.98	2.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	57.21	5.64	1.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	50.36	3.58	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	66.64	3.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	55.11	6.05	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	57.00	12.56	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	71.31	19.16	5.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	89.27	18.54	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	50.43	5.81	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	87.84	35.79	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	70.82	11.58	4.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.45	6.57	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	51.39	5.07	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	46.98	4.27	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	54.90	3.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	56.61	6.64	10.43
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	61.69	5.12	2.42
immature langerhans cells, donor1	11904-125F5	18.65	4.12	2.42
immature langerhans cells, donor2	11905-125F6	10.30	5.54	0.00
insula, adult, pool1	10039-101F3	49.11	5.39	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	79.34	7.15	0.65
kidney, adult, pool1	10017-101C8	46.46	5.21	0.30
kidney, fetal, pool1	10045-101F9	31.83	3.40	0.92
large cell lung carcinoma cell line:IA-LM	10509-107D5	45.30	9.23	3.69
large cell lung carcinoma cell line:NCI-H460	10839-111E2	46.45	4.42	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.65	11.93	0.18
left atrium, adult, donor1	10079-102A7	68.65	3.27	0.00
left ventricle, adult, donor1	10078-102A6	91.02	3.54	0.00
leiomyoblastoma cell line:G-402	10721-110A1	70.59	5.75	1.09
leiomyoma cell line:10964C	10569-108B2	28.02	1.80	0.36
leiomyoma cell line:15242A	10570-108B3	16.85	2.17	0.00
leiomyoma cell line:15425	10571-108B4	26.71	0.97	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	38.10	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	51.23	12.55	6.27
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	52.54	6.38	1.06
liposarcoma cell line:KMLS-1	10782-110G8	30.46	2.97	1.41
liposarcoma cell line:SW 872	10726-110A6	48.61	7.80	1.95
liver, adult, pool1	10018-101C9	50.89	7.29	0.00
liver, fetal, pool1	10086-102B5	28.22	3.76	0.00
locus coeruleus - adult, donor10196	10182-103D2	32.37	2.33	0.00
locus coeruleus, adult, donor10252	10165-103B3	33.03	3.14	0.37
locus coeruleus, adult, donor10258	10375-105G6	36.68	1.97	0.00
locus coeruleus, newborn, donor10223	10362-105F2	17.67	2.94	0.42
lung adenocarcinoma cell line:A549	10499-107C4	39.72	7.61	3.32
lung adenocarcinoma cell line:PC-14	10408-106B3	19.99	3.45	5.52
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.69	5.14	0.92
lung, adult, pool1	10019-101D1	25.04	2.01	1.42
lung, fetal, donor1	10068-101I5	28.26	1.71	3.14
lung, right lower lobe, adult, donor1	10075-102A3	33.45	3.21	0.00
lymph node, adult, donor1	10077-102A5	27.93	0.95	0.00
lymphangiectasia cell line:DS-1	10727-110A7	45.81	10.08	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	54.94	16.00	10.72
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	51.82	9.34	1.70
mature adipocyte, donor1	12231-129F8	67.49	9.32	0.00
mature adipocyte, donor2	12232-129F9	51.05	10.17	0.00
mature adipocyte, donor3	12233-129G1	45.99	6.40	0.00
mature adipocyte, donor4	12234-129G2	55.01	5.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	39.31	5.24	3.57
medial frontal gyrus - adult, donor10196	10170-103B8	49.63	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	31.82	3.13	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	51.78	3.81	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	35.40	5.12	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	44.38	4.39	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	28.44	4.46	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	25.04	11.56	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.30	3.23	0.00
medulla oblongata - adult, donor10196	10174-103C3	44.78	3.89	0.00
medulla oblongata, adult, donor10252	10155-103A2	25.39	4.80	0.00
medulla oblongata, adult, pool1	10038-101F2	35.26	3.84	0.08
medulla oblongata, newborn, donor10223	10361-105F1	29.51	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	65.54	15.72	1.33
medulloblastoma cell line:ONS-76	10759-110E3	71.04	6.97	0.49
melanoma cell line:COLO 679	10514-107E1	68.71	10.35	3.74
melanoma cell line:G-361	10465-106H6	46.96	5.16	1.63
meningioma cell line:HKBMM	10691-109F7	27.50	3.44	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	109.26	21.15	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	116.65	15.81	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	47.72	5.06	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	28.54	2.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.60	2.07	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.79	0.84	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.99	2.12	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	20.82	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.72	2.75	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	27.37	2.76	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	38.60	3.45	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	32.81	4.05	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	28.45	3.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	14.49	1.98	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	29.06	3.32	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	27.23	3.49	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.17	3.27	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	21.21	2.16	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.38	2.38	1.03
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.92	2.51	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	43.63	3.36	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	29.29	2.69	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.87	3.76	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	21.72	3.31	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	25.47	2.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	42.10	5.47	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.99	2.74	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	30.44	2.30	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.63	2.88	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	23.72	1.85	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.30	3.06	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	28.09	2.37	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	32.22	2.75	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	16.22	3.71	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.32	1.73	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	31.90	2.68	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	31.97	1.92	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	2.93	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.51	2.69	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.97	2.87	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.08	3.44	2.58
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	41.90	2.27	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	40.74	7.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	38.91	2.67	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	34.35	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	31.49	1.55	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	39.88	2.10	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	25.83	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	36.17	2.96	3.56
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	4.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.97	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.63	2.41	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	17.93	2.44	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	16.68	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.74	0.00	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.46	2.49	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	18.71	1.34	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	34.30	9.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	33.73	11.01	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	58.39	16.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	50.47	17.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	58.52	20.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	98.73	19.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	95.95	17.44	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	93.76	31.68	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	67.36	13.96	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	13.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	51.89	9.88	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	49.01	6.94	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	41.86	9.73	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	44.82	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	27.85	2.32	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	43.70	5.43	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	50.04	23.17	7.18
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	17.09	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	63.29	11.51	6.88
mesothelioma cell line:Mero-25	10850-111F4	43.80	7.26	0.45
mesothelioma cell line:Mero-41	10851-111F5	53.05	5.38	1.22
mesothelioma cell line:Mero-48a	10852-111F6	51.59	5.98	1.33
mesothelioma cell line:Mero-82	10853-111F7	38.63	5.78	1.31
mesothelioma cell line:Mero-83	10854-111F8	41.87	17.02	1.19
mesothelioma cell line:Mero-84	10855-111F9	51.57	12.13	1.77
mesothelioma cell line:Mero-95	10856-111G1	32.71	6.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	55.66	6.46	0.33
mesothelioma cell line:NCI-H226	10846-111E9	43.62	10.32	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	44.24	6.49	0.85
mesothelioma cell line:NCI-H28	10845-111E8	72.78	8.14	1.27
mesothelioma cell line:No36	10857-111G2	59.37	25.12	0.65
mesothelioma cell line:ONE58	10858-111G3	43.35	10.30	0.27
migratory langerhans cells, donor1	11901-125F2	27.06	1.92	1.73
migratory langerhans cells, donor2	11902-125F3	28.82	0.98	0.98
migratory langerhans cells, donor3	11903-125F4	38.23	2.15	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	40.48	6.53	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	73.33	5.09	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	53.67	3.92	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	57.66	9.70	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	50.45	10.90	8.87
myeloma cell line:PCM6	10474-106I6	55.35	4.74	1.58
myxofibrosarcoma cell line:MFH-ino	10600-108E6	47.69	9.64	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	58.45	6.67	1.37
nasal epithelial cells, donor1, tech_rep1	12226-129F3	39.56	5.13	2.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	47.87	8.75	3.97
nasal epithelial cells, donor2	12227-129F4	27.05	4.97	3.31
neuroblastoma cell line:CHP-134	10508-107D4	144.71	20.94	27.84
neuroblastoma cell line:NB-1	10539-107G8	120.86	21.14	9.17
neuroblastoma cell line:NBsusSR	10607-108F4	67.27	8.44	0.63
neuroblastoma cell line:NH-12	10555-107I6	76.59	19.75	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.86	3.56	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	48.78	4.28	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	60.58	12.88	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	61.03	8.90	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	39.66	3.73	0.27
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	25.54	4.40	5.58
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	212.13	18.41	12.01
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.85	4.17	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	41.52	3.68	0.53
nucleus accumbens, adult, pool1	10037-101F1	39.75	3.47	0.37
occipital cortex - adult, donor10196	10172-103C1	55.63	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	27.10	5.64	0.00
occipital cortex, newborn, donor10223	10355-105E4	33.12	1.82	0.00
occipital lobe, adult, donor1	10076-102A4	55.37	6.30	0.00
occipital lobe, fetal, donor1	10073-102A1	51.92	2.15	0.86
occipital pole, adult, pool1	10036-101E9	39.11	4.10	0.16
olfactory region, adult	10195-103E6	31.33	1.91	0.00
optic nerve, donor1	10277-104E7	32.02	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	61.97	12.99	7.06
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	37.78	9.62	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	47.07	5.76	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	24.26	3.23	0.92
osteoclastoma cell line:Hs 706.T	10704-109H2	22.64	4.12	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	43.91	9.34	12.15
osteosarcoma cell line:HS-Os-1	10558-107I9	25.66	4.67	3.39
ovary, adult, pool1	10020-101D2	20.35	0.96	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	45.83	5.32	1.65
pancreas, adult, donor1	10049-101G4	34.80	5.64	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	41.93	10.06	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	54.51	10.05	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.85	10.60	8.11
paracentral gyrus, adult, pool1	10035-101E8	37.71	3.94	0.27
parietal cortex, adult, donor10258	10373-105G4	22.02	3.67	0.00
parietal lobe - adult, donor10196	10171-103B9	49.85	5.64	0.00
parietal lobe, adult, donor10252	10157-103A4	26.51	4.85	0.00
parietal lobe, adult, pool1	10034-101E7	36.48	5.73	0.09
parietal lobe, fetal, donor1	10072-101I9	60.13	0.97	1.94
parietal lobe, newborn, donor10223	10356-105E5	40.38	2.24	0.00
parotid gland, adult	10199-103F1	42.55	1.85	0.00
penis, adult	10200-103F2	47.27	1.07	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.63	1.86	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	83.05	9.47	2.19
pineal gland - adult, donor10196	10179-103C8	37.41	3.87	0.00
pineal gland, adult, donor10252	10160-103A7	49.75	1.78	1.18
pineal gland, adult, donor10258	10377-105G8	43.27	3.14	0.00
pituitary gland - adult, donor10196	10180-103C9	41.48	4.05	0.00
pituitary gland, adult, donor10252	10162-103A9	44.82	6.78	0.00
pituitary gland, adult, donor10258	10378-105G9	41.71	1.70	0.85
placenta, adult, pool1	10021-101D3	38.49	4.95	1.29
plasma cell leukemia cell line:ARH-77	10840-111E3	52.71	11.92	2.78
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.15	2.18	3.58
pons, adult, pool1	10033-101E6	33.31	6.80	0.17
postcentral gyrus, adult, pool1	10032-101E5	42.45	4.45	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	60.65	16.73	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	60.59	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	76.76	20.39	9.76
prostate cancer cell line:PC-3	10439-106E7	152.82	21.96	19.60
prostate, adult, pool1	10022-101D4	26.12	1.72	0.36
putamen, adult, donor10196	10176-103C5	46.50	2.83	0.24
putamen, adult, donor10252	10152-102I8	60.78	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	9.84	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	40.11	5.56	0.00
putamen, newborn, donor10223	10365-105F5	15.74	3.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	18.33	7.86	2.04
rectum, fetal, donor1	10067-101I4	43.12	5.56	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	64.45	3.39	2.54
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	23.61	2.49	4.14
retina, adult, pool1	10030-101E3	40.65	3.08	0.20
retinoblastoma cell line:Y79	10475-106I7	94.83	12.21	14.55
rhabdomyosarcoma cell line:KYM-1	10787-110H4	49.79	6.76	1.23
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	87.17	15.75	13.78
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.83	1.52	1.52
salivary acinar cells, donor1	11771-123I7	22.82	2.91	0.49
salivary acinar cells, donor2	11772-123I8	23.96	2.20	0.14
salivary acinar cells, donor3	11773-123I9	23.17	1.32	0.66
salivary gland, adult, pool1	10093-102C3	45.76	6.86	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	20.57	3.54	2.70
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.15	4.58	2.35
seminal vesicle, adult	10201-103F3	41.80	2.65	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	44.70	12.63	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	39.51	9.81	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	72.25	10.04	4.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	129.22	29.15	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	61.67	5.19	3.43
signet ring carcinoma cell line:NUGC-4	10483-107A6	109.80	22.32	3.35
skeletal muscle - soleus muscle, donor1	10282-104F3	187.97	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	98.83	3.84	0.24
skeletal muscle, fetal, donor1	10066-101I3	57.29	5.03	3.02
skin, adult, donor1	10074-102A2	54.28	0.00	0.00
skin, fetal, donor1	10065-101I2	68.80	3.16	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	67.04	14.01	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	38.14	11.35	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	78.64	8.29	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	110.10	16.98	19.94
small cell lung carcinoma cell line:NCI-H82	10842-111E5	42.95	8.36	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	30.07	6.76	0.00
small intestine, adult, pool1	10024-101D6	51.24	4.66	4.42
small intestine, fetal, donor1	10064-101I1	51.60	2.70	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.98	2.05	0.00
smooth muscle, adult, pool1	10048-101G3	27.65	0.78	0.26
somatostatinoma cell line:QGP-1	10781-110G7	48.78	2.68	0.80
spinal cord - adult, donor10196	10181-103D1	35.10	1.38	0.23
spinal cord, adult, donor10252	10159-103A6	21.29	3.55	1.18
spinal cord, adult, donor10258	10369-105F9	24.90	3.46	0.00
spinal cord, fetal, donor1	10056-101H2	52.45	4.27	0.00
spinal cord, newborn, donor10223	10359-105E8	27.55	4.59	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	33.60	3.14	0.75
spleen, adult, pool1	10025-101D7	30.62	3.08	2.09
spleen, fetal, pool1	10044-101F8	23.84	3.34	3.10
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	48.55	9.21	8.49
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	59.43	10.25	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	71.99	13.63	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.79	5.86	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	55.60	9.12	2.25
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	95.31	7.20	2.54
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	43.58	8.88	1.27
stomach, fetal, donor1	10062-101H8	64.08	1.07	0.00
submaxillary gland, adult	10202-103F4	39.31	5.13	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	25.76	3.12	0.00
substantia nigra, adult, donor10258	10371-105G2	30.00	6.72	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	82.54	10.09	6.65
temporal lobe, adult, pool1	10031-101E4	42.72	5.43	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	47.72	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.48	3.52	0.44
tenocyte, donor1	11763-123H8	30.72	2.79	1.40
tenocyte, donor2	11765-123I1	20.98	0.76	1.14
tenocyte, donor3	11768-123I4	24.46	2.97	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	102.32	11.73	1.70
teratocarcinoma cell line:NCR-G1	10798-110I6	55.49	12.64	1.23
teratocarcinoma cell line:PA-1	10807-111A6	49.44	10.38	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	79.22	17.90	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	62.02	4.16	2.27
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	29.12	4.47	2.18
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	47.23	5.86	0.98
testis, adult, pool1	10026-101D8	31.67	4.62	82.14
testis, adult, pool2	10096-102C6	42.85	9.02	25.26
thalamus - adult, donor10196	10168-103B6	41.95	4.42	0.00
thalamus, adult, donor10252	10154-103A1	27.35	3.59	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	20.02	10.78	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.14	1.81	0.00
thalamus, newborn, donor10223	10366-105F6	25.31	4.03	0.00
throat, adult	10209-103G2	54.43	3.99	0.25
throat, fetal, donor1	10061-101H7	55.76	2.74	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	78.10	4.17	3.78
thymus, adult, pool1	10027-101D9	29.23	4.18	12.63
thymus, fetal, pool1	10043-101F7	24.42	3.74	4.57
thyroid carcinoma cell line:KHM-5M	10776-110G2	58.10	5.45	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	37.16	6.15	0.56
thyroid, adult, pool1	10028-101E1	40.40	4.57	0.28
thyroid, fetal, donor1	10060-101H6	49.04	1.05	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	30.80	0.00	0.00
tongue, adult	10203-103F5	67.21	5.58	0.23
tongue, fetal, donor1	10059-101H5	113.10	3.94	0.00
tonsil, adult, pool1	10047-101G2	39.47	5.51	2.40
trachea, adult, pool1	10029-101E2	33.86	4.58	1.31
trachea, fetal, donor1	10058-101H4	54.63	2.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	49.95	3.90	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	65.75	10.94	10.23
transitional-cell carcinoma cell line:JMSU1	10492-107B6	41.52	7.05	5.01
tridermal teratoma cell line:HGRT	10694-109G1	49.47	3.81	5.71
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	41.73	5.76	0.51
umbilical cord, fetal, donor1	10057-101H3	45.90	0.00	0.00
uterus, adult, pool1	10100-102D1	25.76	2.05	0.51
uterus, fetal, donor1	10055-101H1	34.30	3.58	1.02
vagina, adult	10204-103F6	16.80	1.29	0.65
vein, adult	10191-103E2	32.00	2.63	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	31.51	8.81	1.07